- Home
- EKSO vs CODX Comparison
EKSO vs CODX Comparison
Compare EKSO & CODX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EKSO
- CODX
- Stock Information
- Founded
- EKSO 2005
- CODX 2013
- Country
- EKSO United States
- CODX United States
- Employees
- EKSO N/A
- CODX N/A
- Industry
- EKSO Medical/Dental Instruments
- CODX Medical/Dental Instruments
- Sector
- EKSO Health Care
- CODX Health Care
- Exchange
- EKSO Nasdaq
- CODX Nasdaq
- Market Cap
- EKSO 7.7M
- CODX 9.8M
- IPO Year
- EKSO N/A
- CODX 2017
- Fundamental
- Price
- EKSO $3.34
- CODX $0.26
- Analyst Decision
- EKSO Strong Buy
- CODX Buy
- Analyst Count
- EKSO 2
- CODX 2
- Target Price
- EKSO $37.50
- CODX $5.50
- AVG Volume (30 Days)
- EKSO 269.8K
- CODX 1.1M
- Earning Date
- EKSO 07-28-2025
- CODX 08-07-2025
- Dividend Yield
- EKSO N/A
- CODX N/A
- EPS Growth
- EKSO N/A
- CODX N/A
- EPS
- EKSO N/A
- CODX N/A
- Revenue
- EKSO $17,544,000.00
- CODX $3,497,583.00
- Revenue This Year
- EKSO $0.20
- CODX N/A
- Revenue Next Year
- EKSO $42.29
- CODX $42.11
- P/E Ratio
- EKSO N/A
- CODX N/A
- Revenue Growth
- EKSO N/A
- CODX N/A
- 52 Week Low
- EKSO $2.73
- CODX $0.23
- 52 Week High
- EKSO $22.95
- CODX $2.23
- Technical
- Relative Strength Index (RSI)
- EKSO 40.21
- CODX 46.30
- Support Level
- EKSO $3.16
- CODX $0.24
- Resistance Level
- EKSO $3.50
- CODX $0.29
- Average True Range (ATR)
- EKSO 0.30
- CODX 0.02
- MACD
- EKSO 0.06
- CODX 0.00
- Stochastic Oscillator
- EKSO 35.63
- CODX 40.34
About EKSO Ekso Bionics Holdings Inc.
Ekso Bionics Holdings Inc designs, develops and sells exoskeleton technology used in healthcare and industrial markets. The wearable exoskeletons are to be worn over clothes and controlled by a trained operator to augment human strength, endurance, and mobility. The company's segments are Enterprise Health and Personal Health. All of the company's operations are held in the United States. The regions the company operates in are the Americas, EMEA, and APAC.
About CODX Co-Diagnostics Inc.
Co-Diagnostics Inc is a molecular diagnostics company. It develops, licenses, and commercializes molecular technologies such as lab systems (MDx device) and manufacture and sell reagents used for tests that are designed using the detection and/or analysis of nucleic acid molecules (DNA or RNA). CDI's low-cost system uses its tests to diagnose tuberculosis, Zika, hepatitis B and C, Malaria, dengue and HIV.The Company's technologies are utilized for tests that are designed using the detection and/or analysis of nucleic acid molecules (DNA or RNA). The Company also uses its proprietary technology to design specific tests for its Co-Dx PCR platform and to locate genetic markers for use in applications other than infectious diseases.